Cytologic criteria for subclassification of Hodgkin's disease using fine-needle aspiration

A T Moriarty1, E R Banks, T Bloch

  • 1Department of Pathology, Indiana University School of Medicine, Indianapolis.

Diagnostic Cytopathology
|January 1, 1989
PubMed

Insights

Fine-needle aspiration (FNA) can diagnose Hodgkin's disease (HD), but subtyping remains challenging. Quantifying Reed-Sternberg cells helps identify lymphocyte-depleted HD but not other subtypes.

Area of Science:

  • Oncology
  • Pathology
  • Cytopathology

Background:

  • Hodgkin's disease (HD) diagnosis increasingly utilizes fine-needle aspiration (FNA).
  • Established criteria for subtyping HD into nodular sclerosis (NS), mixed-cellularity (MC), lymphocyte-depleted (LD), and lymphocyte-predominant (LP) via FNA are lacking.
  • Accurate subtyping is crucial for appropriate patient management and treatment strategies.

Purpose of the Study:

  • To evaluate the efficacy of FNA in subclassifying Hodgkin's disease.
  • To determine if quantitative analysis of Reed-Sternberg (RS) cells can differentiate HD subtypes.
  • To assess the utility of fibrosis and RS variants in subtyping.

Main Methods:

  • Retrospective review of FNA cases of Hodgkin's disease with confirmatory surgical biopsies over a 5-year period.
  • Quantitative analysis of Reed-Sternberg (RS) cells in cytologic specimens.
  • Statistical analysis using analysis of variance (ANOVA) to compare RS cell counts across subtypes.
  • Qualitative assessment of fibrosis and RS variants.

Main Results:

  • Lymphocyte-depleted (LD) HD showed the highest mean number of RS cells (51).
  • Nodular sclerosis (NS) and mixed-cellularity (MC) HD had similar, lower mean RS cell counts (7 and 6, respectively).
  • Fibrosis and RS variants were not reliable indicators for subtyping HD.
  • Only one case of lymphocyte-predominant (LP) HD was identified, precluding statistical analysis.

Conclusions:

  • Quantitation of RS cells can aid in identifying lymphocyte-depleted (LD) Hodgkin's disease (HD).
  • Distinguishing between nodular sclerosis (NS) and mixed-cellularity (MC) HD based solely on RS cell counts is unreliable.
  • Fine-needle aspiration (FNA) is suitable for diagnosing HD, staging, and assessing chemotherapy efficacy, but subtyping should still rely on histologic examination of excised lymph nodes.

Related Concept Videos